AI Article Synopsis
- The study explores how lncRNA ZFAS1 contributes to a type of cell death called pyroptosis in intervertebral disc degeneration caused by TNF-α.
- Silencing ZFAS1 reduces pyroptosis in these nucleus pulposus cells (NPCs) by altering the interaction between miR-155-3p and METTL14, which are key players in this process.
- The findings suggest that targeting the ZFAS1/miR-155-3p/METTL14 pathway could have potential therapeutic implications for treating intervertebral disc degeneration.
Article Abstract
Background: This study investigates the mechanism of lncRNA ZFAS1 in pyroptosis of TNF-α-induced nucleus pulposus cells (NPCs) in intervertebral disc degeneration (IDD).
Methods: Mouse NPCs were isolated and induced by TNF-α to establish a cell model of IDD. The cell viability was evaluated by MTT assay. NLRP3, GSDMD-N, and cleaved-Caspase1 expressions were detected by Western blot. IL-1β and IL-18 contents were detected by ELISA. RT-qPCR was performed to determine ZFAS1, miR-155-3p, and METTL14 expressions. After intervening in ZFAS1 expression, the effect of ZFAS1 on pyroptosis was verified by Western blot and ELISA assays. RNA pull down or dual luciferase assay verified the binding between ZFAS1, miR-155-3p, and METTL14.
Results: TNF-α induced pyroptosis of NPCs and promoted ZFAS1 expression. Silence of ZFAS1 repressed pyroptosis of TNF-α-induced NPCs. Mechanistically, ZFAS1 upregulated the transcription of METTL14 by competitively binding to miR-155-3p, thus enhancing NLRP3/Caspase-1-mediated NPC pyroptosis. Inhibition of miR-155-3p or overexpression of METTL14 alleviated the inhibitory effect of ZFAS1 silencing on TNF-α-treated NPC pyroptosis.
Conclusion: ZFAS1 facilitates NLRP3/Caspase-1-mediated pyroptosis of NPCs in IDD via miR-155-3p/METTL14 axis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11863448 | PMC |
| http://dx.doi.org/10.1186/s13018-025-05471-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mechanism of lncRNA ZFAS1 mediating nucleus pulposus cell pyroptosis in intervertebral disc degeneration.
J Orthop Surg Res
February 2025
Department of Minimally Invasive Spine Surgery, Bengbu First People's Hospital, Bengbu, 233000, China.
Article Synopsis
- The study explores how lncRNA ZFAS1 contributes to a type of cell death called pyroptosis in intervertebral disc degeneration caused by TNF-α.
- Silencing ZFAS1 reduces pyroptosis in these nucleus pulposus cells (NPCs) by altering the interaction between miR-155-3p and METTL14, which are key players in this process.
- The findings suggest that targeting the ZFAS1/miR-155-3p/METTL14 pathway could have potential therapeutic implications for treating intervertebral disc degeneration.
IGF2BP3 prefers to regulate alternative splicing of genes associated with the progression of gastric cancer in AGS cells.
Discov Oncol
February 2025
Breast and Thyroid Surgery Department, The Affiliated Tumor Hospital of Xinjiang Medical University, Ürümqi, 830011, China.
Gastric cancer (GC) has become the fifth largest malignant tumor in the world, with a mortality rate ranking fourth. IGF2BP3, as a multifunctional RNA binding protein, is involved in regulating alternative splicing (AS) and mA modification, and plays a carcinogenic role in the development of gastric cancer, while little is known about the impact of IGF2BP3 on alternative splicing in gastric cancer cells and the underlying mechanism. In this study, we overexpressed IGF2BP3 (IGF2BP3-OE) in gastric cancer AGS cells and obtained transcriptome sequencing data (RNA-seq) to explore the effects of IGF2BP3 on gene expression and AS.
View Article and Find Full Text PDFCharacterization of lncRNAs contributing to drug resistance in epithelial ovarian cancer.
Med Oncol
February 2025
Department of Medical Genetics, Faculty of Medicine, Pamukkale University, Denizli, Turkey.
Epithelial ovarian cancer (EOC) is the second leading cause of death among women with gynecological cancers, particularly in high-income countries. Despite significant advancements in molecular oncology and an initially positive response to primary chemotherapy, the development of drug resistance remains a major challenge in the effective management of EOC. Consequently, there is an urgent need for innovative biological markers that can enable early diagnosis and provide more accurate predictions of recurrence risk in ovarian cancer patients.
View Article and Find Full Text PDFLong non-coding RNA ZFAS1 promotes ferroptosis by regulating the miR-185-5p/SLC25A28 axis in clear cell renal cell carcinoma.
Int J Biol Macromol
February 2025
Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China. Electronic address:
Ferroptosis is a novel, iron-dependent regulated cell death mode. The biochemical features of ferroptosis include iron accumulation, lipid peroxidation, inhibition of glutathione peroxidase 4 (GPX4) and antioxidant glutathione (GSH) decrease through inhibition of the system xc transporter. Zinc finger NFX1 type-containing 1 (ZNFX1) antisense RNA 1 (ZFAS1) is a long non-coding RNA that has been identified as an oncogene in various types of cancers.
View Article and Find Full Text PDFBlood Circulating LncRNAs: SNHG5 and ZFAS1 as Biomarkers Reflecting Cachexia Incidence in Chronic Heart Failure Patients.
J Nutr
March 2025
Department of Human Physiology of the Chair of Preclinical Sciences, Medical University in Lublin, Lublin, Poland.
Background: Systemic inflammation plays a crucial role in the development and progression of chronic heart failure (CHF) across all phenotypes. The continuous release of proinflammatory cytokines causes muscle atrophy and adipocyte breakdown, ultimately resulting in cachexia. Long noncoding RNAs (lncRNAs) are emerging as potential biomarkers associated with cachexia, as they indirectly regulate muscle and fat tissue metabolism.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!